Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 173

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cytoplasmic induction and over‐expression of cyclooxygenase‐2 in human prostate cancer: implications for prevention and treatment

Madaan, S., Abel, P.D., Chaudhary, K.S., Hewitt, R., Stott, M.A., Stamp, G.W.H., Lalani, E.‐N. · 2000 · BJU International

Abstract

Objective To assess the level and morphological distribution of cyclooxygenase (COX)‐1 and ‐2 in human prostates and to determine any association with the Gleason grade of prostate cancer. Materials and methods The study comprised 30 samples from patients with benign prostatic hyperplasia (BPH) and 82 with prostate cancer. Immunohistochemistry was used to assess the expression of COX‐1 and ‐2, and 13 samples were also assessed using immunoblotting (six BPH and seven cancers). Results For both BPH and prostate cancer, COX‐1 expression was primarily in the fibromuscular stroma, with variable weak cytoplasmic expression in glandular/neoplastic epithelial cells. In contrast, COX‐2 expression differed markedly between BPH and cancer. In BPH there was membranous expression of COX‐2 in luminal glandular cells and no stromal expression. In cancer the stromal expression of COX‐2 was unaltered, but expression by tumour cells was significantly greater ( P = 0.008), with a change in the staining pattern from membranous to cytoplasmic ( P < 0.001). COX‐2 expression was significantly higher in poorly differentiated than in well differentiated tumours ( P < 0.001). These results were supported by immunoblotting, which showed similar levels of COX‐1 in both BPH and cancer, but four times greater expression of COX‐2 in cancer than in BPH. Conclusion This is the first study to assess the co‐expression of COX‐1 and COX‐2 proteins in benign and malignant human prostates, and showed the induction and significantly greater expression of COX‐2 in cancer, which was also associated with tumour grade. The regular use of nonsteroidal anti‐inflammatory drugs is associated with a reduced incidence of cancers. The present results provide the basis for a potential role for COX‐2 inhibitors in the prevention and treatment of prostate cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1464-410x.2000.00867.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 173

Metadata

Authors
Madaan, S., Abel, P. D., Chaudhary, K. S., Hewitt, R., Stott, M. A., Stamp, G. W. H., & Lalani, E. ‐.
Venue
BJU International
Publisher
Wiley
Published
2000-10
Volume
86
Issue
6
Pages
736-741
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W1837402230
Cited by
173
References
2
FWCI
6.60
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytoplasmic induction and over‐expression of cyclooxygenase‐2 in human prostate cancer: implications for prevention and treatment. https://app.cochat.ai/papers/10.1046/j.1464-410x.2000.00867.x
The paper
Madaan, S., Abel, P. D., Chaudhary, K. S., Hewitt, R., Stott, M. A., Stamp, G. W. H., & Lalani, E. ‐. (2000). Cytoplasmic induction and over‐expression of cyclooxygenase‐2 in human prostate cancer: implications for prevention and treatment. BJU International. https://doi.org/10.1046/j.1464-410x.2000.00867.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.